Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C2UQ
|
||||
Former ID |
DNC007463
|
||||
Drug Name |
MCL-428
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528655] | ||
Structure |
Download2D MOL |
||||
Formula |
C28H34N2O2
|
||||
Canonical SMILES |
C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)OC(=O)NC5=CC=CC=C5)CC6<br />CCC6
|
||||
InChI |
1S/C28H34N2O2/c31-27(29-22-9-2-1-3-10-22)32-23-13-12-21-17-26-24-11-4-5-14-28(24,25(21)18-23)15-16-30(26)19-20-7-6-8-20/h1-3,9-10,12-13,18,20,24,26H,4-8,11,14-17,19H2,(H,29,31)
|
||||
InChIKey |
UDWPHJLFGHTIHV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528655] | |
Delta-type opioid receptor | Target Info | Inhibitor | [528655] | ||
Kappa-type opioid receptor | Target Info | Inhibitor | [528655] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.